The development of medical biosensors and nanobiosensors

Research output: Contribution to conferenceAbstractpeer-review

Abstract

We describe here the development of various technologiesdeveloped in our laboratory over the years that may be used in theclinical environment. These are based on the fields of chemistry,molecular biology, physics, data mining and chemical engineering.Most have been validated using real-life samples from Africa, Israel,USA, and South America and are discussed as follows:1. Chemiluminescence-basedfiber-opticimmunosensorstopatients infected with viral pathogens (Ebola, Dengue, Hep-aptitis C, West Nile virus, Rift Valley fever) – the BioPenconcept.2. Detection of negative stranded RNA viruses (CCHF, influenza)using reverse genetics cell sensors.3. Biochip immunosensors based on electrogenerated filmsdeposited on ITO chip surfaces.4. Label-less nanometer scale ‘nanoantenna’ immunosensors usingRaman and IR spectroscopies to Epstein Barr EBNA1 or GIPC1antigens.5. Magnetic liquid fiber guide immunosensor for GIPC1 cancer anti-gen.6. Diagnostic phagocytic chemiluminescent imprints to identify
Original languageEnglish
PagesS15-S15
DOIs
StatePublished - Sep 2011
EventEuropean Biotechnology Congress 2011 -
Duration: 28 Sep 20111 Oct 2011

Conference

ConferenceEuropean Biotechnology Congress 2011
Period28/09/111/10/11

Fingerprint

Dive into the research topics of 'The development of medical biosensors and nanobiosensors'. Together they form a unique fingerprint.

Cite this